Takeda Pharmaceutical Co ADR (NYSE:TAK) traded at $14.05 at close of the session on current trade day and made a downward move of -2.02% on its previous day’s price.
Looking at the stock we see that its previous close was $14.34 and the beta (5Y monthly) reads 0.498 with the day’s price range being $14.03 – $14.215. The company has a trailing 12-month PE ratio of 46.04. In terms of its 52-week price range, TAK has a high of $15.08 and a low of $12.57. The company’s stock has lost about -5.07% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Takeda Pharmaceutical Co ADR has a market cap of $44.54 billion and is expected to release its quarterly earnings report in November. With its Forward Dividend at 0.29 and a yield of 2.08%, the company’s investors could be anxious for the TAK stock to gain ahead of the earnings release.
On the other hand, looking at the outlook for the TAK stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Buy.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Takeda Pharmaceutical Co ADR (TAK) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the TAK stock currently stands at 2.23, and the current price level is -2.91% off its SMA20 and -3.47% from its 50-day simple moving average. The RSI (14) is pointing at 34.73 while the volatility over the past week is 1.08% and jumps to 1.01% over the past one month. The beta value is 0.57, while the average true range (ATR) is currently pointing at 0.17.
Coming back to Takeda Pharmaceutical Co ADR (NYSE:TAK), we note that the average 3-month trading volume was 2.24 million, while that of the preceding 10-day period stands at 1.88 million. Current shares outstanding are 3.17 billion.
The insiders hold 0.02% of the company’s shares while institutions hold 5.03%. The data shows that short shares as of 2024-09-30, stood at 8.42 million at a short ratio of 4.7. This represents a 27.00 short interest in shares outstanding on 2024-09-30. Shares short rose in September from the previous month at 8.23 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -1.54% down in year-to-date price movement.
